Table 1.
Socio-demographic and clinical characteristics of the sample divided according to antidepressant response and levels of significance of the observed differences (Student's t test and Chi-square). HDRS, Hamilton Depression Rating Scale.
| Total (n = 60) |
HDRS reduction > 50% |
||||
|---|---|---|---|---|---|
| Yes (n 55) | No (n = 5) | t or χ2 | p-value | ||
| Age | 54.82 ± 14.17 | 54.58 ± 14.03 | 57.4 ± 17.21 | -0.42 | 0.674 |
| Sex (males - %) | 27–45% | 25–44% | 2–40% | 0.06 | 0.814 |
| Psychiatric history (positive - %) | 36–60% | 32–58% | 4–80% | 0.91 | 0.34 |
| Mood disorders history (positive - %) | 30–50% | 26–47% | 4–80% | 1.96 | 0.161 |
| Hospitalization for COVID-19 (yes - %) | 29–48% | 26–47% | 3–60% | 0.28 | 0.585 |
| Days between COVID-19 and depression diagnosis (mean±SD) | 79.25 ± 52.56 | 80.27 ± 53.93 | 64 ± 23.43 | 0.51 | 0.609 |